← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 18, 2017Last known activity
Oct 15, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 3 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT07310719Lead sponsorN/AOct 15, 2025
- NCT07310719Sponsor investigatorN/AOct 15, 2025
- NCT02441673Reponsible party - principal investigatorPhase 2Oct 1, 2017
- NCT02441673Study directorPhase 2Oct 1, 2017
- NCT02441673Lead sponsorPhase 2Oct 1, 2017
- NCT03117595Sponsor investigatorPhase 4Apr 18, 2017
- NCT03117595Lead sponsorPhase 4Apr 18, 2017
Details
- Last known activity
- Oct 15, 2025